10-K: Lifeway Foods Reports Strong 2025 Growth, Resolves Danone Dispute

Lifeway Foods, Inc. announced a significant increase in net sales and net income for fiscal year 2025, alongside key corporate governance changes and strategic investments.

Summary

• Net sales for the year ended December 31, 2025, increased by 13.7% to $212,496 thousand, up from $186,820 thousand in 2024.
• On a comparable basis, adjusting for a strategically exited customer relationship and a distributor shift, net sales increased approximately 19% in fiscal year 2025.
• Gross profit margin improved to 27.4% in 2025 from 26.0% in 2024, driven by higher volumes and favorable conventional milk pricing.
• Net income rose by 53.6% to $13,859 thousand in 2025, compared to $9,025 thousand in 2024.
• Diluted earnings per common share increased to $0.89 in 2025 from $0.60 in 2024.
• The company entered into a Cooperation Agreement with Danone North America PBC on September 30, 2025, which included Board refreshment, a stay of litigation, and waivers of certain Danone rights.
• Lifeway is undertaking a significant capital expenditure project to expand manufacturing capacity and improve packaging efficiency at its Waukesha, Wisconsin facility, with an estimated investment of $48,000 thousand and expected completion in Q4 2026.
• The company purchased 799 mature dairy cows for $2,870 thousand in 2025 as part of an organic milk supply strategy, entering into a 60-month Herd Agreement with a third-party dairy.
• A $1,800 thousand equity investment in Simple Mills was liquidated in February 2025, yielding cash proceeds of $5,206 thousand and a gain on sale of $3,407 thousand.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this filing positively due to strong financial performance, strategic investments in growth, and the resolution of a significant corporate governance dispute. However, the substantial cash outflow for capital expenditures and the competitive market environment warrant a balanced perspective.

Positives

• Net sales increased by 13.7% year-over-year, demonstrating strong top-line growth.
• Gross profit margin improved to 27.4%, indicating enhanced manufacturing efficiencies and favorable input costs.
• Net income surged by 53.6% to $13,859 thousand, reflecting improved profitability.
• Diluted EPS increased significantly from $0.60 to $0.89.
• The Cooperation Agreement with Danone resolves ongoing litigation and provides greater corporate governance stability and clarity.
• Strategic investments in the Waukesha facility expansion are expected to double manufacturing capacity and improve efficiency, positioning the company for future growth.
• The organic milk supply initiative through the Herd Agreement aims to secure raw material supply and potentially generate interest income.
• The successful liquidation of the Simple Mills investment generated a substantial gain of $3,407 thousand.

Negatives

• Cash and cash equivalents decreased significantly from $16,728 thousand in 2024 to $5,571 thousand in 2025, primarily due to increased investing activities.
• Net cash provided by operating activities decreased to $10,948 thousand in 2025 from $12,962 thousand in 2024, mainly due to changes in working capital.
• Selling expenses increased by $5,148 thousand, and as a percentage of net sales, rose from 7.9% to 9.4%, indicating higher marketing investments.
• General and administrative expenses increased by $2,164 thousand, including approximately $6,200 thousand in legal and professional fees related to Danone's unsolicited purchase proposal and non-routine stockholder action in 2025.
• Sales of Drinkable Yogurt and ProBugs Kefir categories decreased significantly year-over-year, indicating challenges in these specific product lines.

Risks

• High level of competition from other domestic kefir producers, dairy products (yogurt), and non-dairy probiotic products, potentially impacting sales and profitability.
• Inability to successfully implement business strategy, including new product development, distribution, acquisitions, and adapting to changing consumer tastes.
• Future investments may not yield expected results, potentially leading to a lack of return on substantial time and resources.
• Interruption of the supply chain due to reliance on single suppliers, labor disputes, natural disasters, or other constraints could disrupt manufacturing and distribution.
• Disruption of manufacturing, distribution chains, or information technology systems, including cybersecurity threats, could adversely affect business operations and reputation.
• Debt and financial obligations, including potential future indebtedness and compliance with loan covenants, could limit financial flexibility and operational strategy.
• Loss of key management or other personnel, or an inability to attract and retain qualified talent, could negatively impact business operations.
• Employee strikes and other labor-related disruptions could adversely affect manufacturing, distribution, and sales.
• Inability to protect intellectual property rights (trademarks, copyrights, trade secrets) could reduce the value of products and brands.
• Concentrated stock ownership by the Smolyansky family, Danone, and Divisadero Street Partners, L.P. could allow them to control stockholder approval matters, potentially conflicting with other stockholders' interests.
• Proposals to acquire the company or stockholder activism could interfere with strategic plans, distract management, incur significant expenses, and impact stock price.
• Protracted and costly litigation regarding the Stockholders Agreement with Danone, despite the current stay.
• The shareholder rights plan (poison pill) could discourage takeovers or other transactions that stockholders may consider favorable, potentially affecting the market price of common stock.
• Adverse economic conditions, such as inflation, rising interest rates, and geopolitical tensions, could negatively affect consumer spending and demand for discretionary products.
• Increasing use of artificial intelligence technologies by competitors, customers, and suppliers could impact the company's competitive position if not effectively adopted.
• Consolidation of customers or the loss of any of the largest customers could negatively impact sales and results of operations, given that two customers accounted for 24% of net sales in 2025.
• Risk of product contamination and product liability claims, which could harm reputation, force recalls, and incur substantial costs.
• Reliance on independent certifications (e.g., organic, SQF) means loss of these certifications could adversely affect market position and sales.
• Increases in the cost of milk and other raw materials could reduce gross margin and profit if not offset by price increases.
• Subject to various food, environmental, and health and safety laws and regulations, with changes potentially increasing compliance costs or restricting actions.

Future Outlook

The company anticipates continued demand for its products driven by an accelerating consumer focus on health and wellness. It plans to complete the Waukesha facility expansion by the fourth fiscal quarter of 2026, which will double manufacturing capacity and improve packaging efficiency. The company expects to fund this project primarily through cash on-hand and cash flow from operations, with additional requirements available under its revolving credit facility. Management believes its strong financial position and liquidity will support future growth initiatives.

Management Comments

• The net sales increase was primarily driven by higher volumes of our branded drinkable kefir.
• The increase in gross profit versus the prior year was driven by higher volumes of our branded products, which provided manufacturing efficiencies and the favorable impact of conventional milk pricing.
• The increase in selling expenses is primarily a result of our continued investments in marketing activities to drive brand awareness and sales volumes.
• We continue to monitor macroeconomic conditions and global trade developments, including inflation in key input costs, recently implemented tariffs, and the potential for additional or modified tariffs or export controls. We do not currently expect these conditions to have a material adverse impact on our operations or financial results.
• We expect the accelerating consumer focus on health and wellness to drive increased demand for our products.
• We remain in a strong financial position, and believe that its cash flow from operations, revolving credit facility, and cash and cash equivalents will continue to provide sufficient liquidity for its working capital needs, capital resource requirements, and growth initiatives and to ensure the continuation of the Company as a going concern.

Industry Context

StockSavvy.ai notes that Lifeway Foods operates in a competitive and evolving dairy and probiotic market. While the company maintains its leadership in kefir, it faces increasing competition from traditional dairy products like yogurt and a growing array of non-dairy probiotic alternatives. The strategic investments in manufacturing capacity and securing organic milk supply are crucial steps to maintain market share and meet anticipated demand in the health and wellness sector. The resolution of the Danone dispute also removes a significant overhang, allowing management to focus more squarely on operational execution and market expansion, aligning with broader industry trends towards consolidation and strategic partnerships.

Comparison to Industry Standards

• Lifeway's 13.7% net sales growth (or 19% comparable growth) in 2025 appears robust, especially when compared to the broader dairy industry which often sees more modest growth rates. For instance, larger dairy players might experience low single-digit growth, while specialized health and wellness brands could see higher, but often more volatile, growth.
• The improvement in gross profit margin to 27.4% suggests effective cost management and pricing power, which is competitive within the specialty food and beverage sector. Many CPG companies strive for gross margins in the 25-35% range, so Lifeway's performance is within a healthy range.
• The significant increase in net income and EPS indicates strong operational leverage and efficiency gains, outperforming many peers in the mature dairy market who might struggle with margin compression due to commodity price volatility and intense competition.
• The substantial capital expenditure for the Waukesha facility expansion ($48,000 thousand) demonstrates a commitment to scaling production, a necessary move to compete with larger players like Danone or General Mills who have extensive manufacturing footprints. This investment is critical for Lifeway to maintain its position as the largest kefir producer in the U.S. and expand into new channels.
• The strategic move to secure organic milk supply through the Herd Agreement is a proactive measure to mitigate raw material price volatility and ensure supply, a common challenge for organic food producers. This approach could provide a competitive advantage over companies reliant solely on spot market purchases.

Management Changes

Corporate Governance

Legal Proceedings

• Danone has filed suit in the Circuit Court of Cook County, Law Division, to enforce the Stockholders Agreement. Pursuant to the Cooperation Agreement, the parties have jointly sought a stay of this pending litigation.
• If the litigation is recommenced, it may be protracted and expensive, and the company may be required to reimburse Danone for its legal fees under certain circumstances.
• The company is involved in various other legal proceedings, claims, disputes, regulatory matters, audits, and proceedings arising in the ordinary course of business, but management believes none are reasonably likely to have a material adverse effect on financial position or results of operations.

Related Party Transactions

• Danone North America PBC and its affiliates beneficially owned approximately 23% of the company's outstanding common stock as of December 31, 2025, making them a significant related party.
• The Smolyansky family members (Julie, Edward, and Ludmila Smolyansky) collectively beneficially owned approximately 44% of the company's outstanding common stock as of December 31, 2025, representing a controlling interest.
• The Cooperation Agreement, dated September 30, 2025, between Lifeway and Danone, outlines specific waivers by Danone regarding its right of first refusal on stock sales by Edward Smolyansky and Ludmila Smolyansky (up to 100,000 shares per month each) and Julie Smolyansky (up to 100,000 shares per month), subject to certain conditions.
• The Stockholders Agreement, dated October 1, 1999 (which Lifeway believes is invalid), grants Danone a right of first refusal on transfers of common stock by certain shareholders and company issuances, and imposes restrictions on prospective purchasers (e.g., not engaged in competing businesses or having significant revenues in related industries).

Stakeholder Impact

• **Shareholders**: The strong financial performance (increased net sales, net income, EPS) is positive for shareholders. The resolution of the Danone dispute reduces uncertainty and potential for costly litigation, which is beneficial. However, the continued presence of the shareholder rights plan may limit opportunities for a control premium in a takeover scenario. Significant capital expenditures could impact short-term cash returns but are aimed at long-term growth.
• **Employees**: The company employed 293 full-time and two part-time employees as of December 31, 2025. Investments in manufacturing capacity could lead to job stability or creation. Labor relations with the unionized workforce in Illinois are noted as amicable, which is positive.
• **Customers**: Increased manufacturing capacity at the Waukesha facility aims to meet increasing sales demand, potentially improving product availability and reliability. However, competition and potential price increases due to rising raw material costs could affect customer pricing.
• **Suppliers**: The organic milk supply initiative through the Herd Agreement creates a stable demand for organic dairy farmers. The company's reliance on single suppliers for certain items poses a risk if those suppliers face disruptions.
• **Creditors**: The company has $0 outstanding under its Revolving Credit Facility and is in compliance with all financial covenants, indicating a healthy debt position and reduced risk for creditors. The extension of the credit facility termination date provides long-term financial stability.

Next Steps

• Hold the 2026 annual meeting of shareholders on or before June 30, 2026, with a slate of seven nominees including the new independent directors.
• Continue with the Waukesha, Wisconsin facility expansion project, with an expected completion during the fourth fiscal quarter of 2026.
• Manage the organic milk supply through the Herd Agreement, with monthly payments from the third-party dairy commencing December 1, 2025.
• Monitor macroeconomic conditions, including inflation and trade policies, and their potential impact on operations and financial results.
• Continue investments in marketing activities to drive brand awareness and sales volumes.

Key Dates

Recommendation

Lifeway Foods has demonstrated strong financial performance in 2025, with significant increases in net sales and net income, and an improved gross profit margin. The resolution of the long-standing dispute with Danone through the Cooperation Agreement is a positive development, reducing corporate governance uncertainty. The company's strategic investments in expanding manufacturing capacity and securing organic milk supply are crucial for future growth. However, the substantial cash outflow for these capital expenditures has significantly reduced the cash balance, and the competitive landscape, along with broader macroeconomic risks, warrants a cautious approach. While the fundamentals are improving, a 'hold' recommendation allows investors to observe the execution of these strategic initiatives and their impact on future cash flows and market position before making further commitments.

Keywords

Kefir, Probiotic, Dairy, Organic Food, SEC Filing, 10-K, Financial Results, Corporate Governance, Shareholder Rights Plan, Danone, Food Manufacturing, Supply Chain, Risk Management, Capital Expenditures, Stockholder Activism